IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.384
EU - Europa 2.550
AS - Asia 1.719
SA - Sud America 521
AF - Africa 105
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.230
SG - Singapore 715
IT - Italia 563
BR - Brasile 440
UA - Ucraina 375
CN - Cina 373
DE - Germania 276
RU - Federazione Russa 259
IE - Irlanda 236
SE - Svezia 222
HK - Hong Kong 182
VN - Vietnam 155
GB - Regno Unito 154
DK - Danimarca 137
CA - Canada 106
FI - Finlandia 101
TR - Turchia 93
FR - Francia 87
KR - Corea 72
NL - Olanda 45
CI - Costa d'Avorio 41
IN - India 41
MA - Marocco 40
MX - Messico 38
AR - Argentina 31
PL - Polonia 23
AT - Austria 17
ZA - Sudafrica 17
BD - Bangladesh 15
BE - Belgio 15
ID - Indonesia 15
JP - Giappone 13
EC - Ecuador 12
VE - Venezuela 11
ES - Italia 10
CL - Cile 8
LT - Lituania 8
PY - Paraguay 8
PK - Pakistan 7
AU - Australia 6
CO - Colombia 6
IR - Iran 6
CH - Svizzera 5
IL - Israele 5
IQ - Iraq 5
RS - Serbia 4
TW - Taiwan 4
EU - Europa 3
JO - Giordania 3
PE - Perù 3
RO - Romania 3
UZ - Uzbekistan 3
AL - Albania 2
BH - Bahrain 2
CR - Costa Rica 2
EG - Egitto 2
HN - Honduras 2
KW - Kuwait 2
NG - Nigeria 2
SA - Arabia Saudita 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DZ - Algeria 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HU - Ungheria 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
PH - Filippine 1
PS - Palestinian Territory 1
SI - Slovenia 1
SR - Suriname 1
SV - El Salvador 1
Totale 10.288
Salva come PNG Salva come JPEG
Città #
Dallas 1.023
Ashburn 553
Singapore 437
Jacksonville 389
Chandler 388
Fairfield 257
Dublin 230
Boardman 226
Hong Kong 180
New York 154
Wilmington 150
Woodbridge 144
Houston 101
Munich 101
Seattle 100
Ann Arbor 97
Beijing 94
Los Angeles 92
Lawrence 87
Princeton 87
The Dalles 85
Des Moines 82
San Mateo 82
Moscow 70
Cambridge 66
Montréal 62
Centro 59
Ho Chi Minh City 59
Hefei 53
Mcallen 49
Ancona 43
Abidjan 41
San Diego 41
São Paulo 40
Hanoi 34
Buffalo 33
Turin 28
Chicago 27
Milan 27
Montreal 26
Mexico City 24
Helsinki 23
Washington 23
Warsaw 21
Pune 17
Redmond 16
Shanghai 16
Brussels 14
Guangzhou 14
London 14
Wuhan 14
Amsterdam 13
Santa Clara 13
Tokyo 13
Nuremberg 12
Orem 12
Poplar 12
Saint Petersburg 12
Boston 11
Castelfidardo 11
Johannesburg 11
Rio de Janeiro 11
Stockholm 11
Brasília 10
Brooklyn 10
Chennai 10
Columbus 10
Denver 10
Florence 10
Norwalk 10
Rome 10
Turku 10
Atlanta 9
Bologna 9
Chiaravalle 9
Manchester 9
Salvador 9
Ankara 8
Kilburn 8
Charlotte 7
Curitiba 7
Haiphong 7
Palermo 7
Belo Horizonte 6
Bergamo 6
Buenos Aires 6
Joinville 6
Massafra 6
Phoenix 6
Porto Alegre 6
Salt Lake City 6
Secaucus 6
Vienna 6
Blumenau 5
Frankfurt am Main 5
Guayaquil 5
Istanbul 5
Mascalucia 5
Osasco 5
Recife 5
Totale 6.509
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 316
Expanding the mosaic functions of intravenous immunoglobulin 225
Insights from comparison of serum IgG4 between T2-eosinophilic asthma and eosinophilic granulomatosis with polyangiitis/idiopathic hypereosinophilic syndrome 207
Use of nailfold capillaroscopy for the early diagnosis of systemic sclerosis in patients with primary biliary cholangitis 186
Colonna vertebrale. Midollo spinale. Imaging 185
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 154
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 145
La scelta della maternità. Una guida alla decisione per le donne con LES 142
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 138
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 136
Cardiac involvement in polymyositis and dermatomyositis 136
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 128
7th International Immunoglobulin Conference: Immunomodulation. 124
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 123
6th International Immunoglobulin Symposium: poster presentations. 122
Overexpression of the cytokine BAFF and autoimmunity risk 122
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 118
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 117
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 115
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 115
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 114
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 113
Subcutaneous IgG in the Myositis Spectrum Disorders 113
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 111
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 109
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 108
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 107
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 107
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 106
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 105
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 105
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 104
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 103
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 103
Bullous SLE: response to methotrexate and relationship with disease activity 103
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 102
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 101
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 100
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 100
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 97
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 97
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 96
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 96
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 95
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 95
Dr. Guerra, et al reply 95
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 93
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 92
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 91
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 91
Alarmins in autoimmune diseases 88
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 88
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 87
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 85
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 84
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 84
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 83
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 83
Subcutaneous immunoglobulins in ocular myositis. 82
Risk factors for Sjögren's syndrome: a case-control study. 81
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 81
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 81
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 81
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 80
La terapia immunosoppressiva nelle miositi refratttarie 78
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 77
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 76
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 76
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 76
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 75
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 74
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 74
Intravenous immunoglobulin as a therapy for autoimmune conditions 73
Ultrasonographic contrast-enhanced study of sicca syndrome 73
The European Society for Immunodeficiencies (ESID) registry 2014 73
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 72
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 71
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 71
Low-dose intravenous immunoglobulin (IVIg) in different immune-mediated conditions 70
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 70
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 69
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 69
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 68
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 67
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 66
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 65
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 65
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 64
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 64
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 63
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 63
Splenic microcalcifications in systemic lupus erythematosus 62
Valutazione obbiettiva strutturata della competenza clinica (osce) 62
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 62
Lessons from the "Euro-Lupus Cohort". 62
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 56
Clinical Characteristics of Anti-Synthetase Syndrome: Analysis From the Classification Criteria for Anti-Synthetase Syndrome Project 55
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 54
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 54
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 54
Totale 9.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 50.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.986
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021657 0 0 0 0 0 58 131 60 120 87 134 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024915 158 40 56 123 143 188 18 34 10 32 19 94
2024/20251.759 134 170 75 31 66 94 178 91 326 158 180 256
2025/20263.302 306 878 629 654 695 140 0 0 0 0 0 0
Totale 10.519